• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

    3/21/24 7:59:00 AM ET
    $AWP
    $HQH
    $HQL
    $THQ
    Trusts Except Educational Religious and Charitable
    Finance
    Finance Companies
    Finance
    Get the next $AWP alert in real time by email

    PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.

    The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has served the Funds well through the years.

    Dr. Omstead was the founder of Tekla Capital Management (TCM) that served as the investment advisor to the Funds from 2001 until October 27, 2023, when a strategic transaction with abrdn was completed and the Funds' advisory agreements transferred to abrdn. Dr. Akus' appointment is part of the orderly transition of Dr. Omstead's responsibilities as the lead portfolio manager to the Funds. It is currently envisaged that Dr. Omstead will continue to serve as the co-lead portfolio manager alongside Dr. Akus through May 31, 2024. Subsequently, Dr. Akus will take over as lead portfolio manager and Dr. Omstead will remain at abrdn and serve in an advisory role to Dr. Akus and the investment team until September 30, 2024.

    Dr. Jason Akus, M.D., MBA brings 23 years of experience as a member of the senior portfolio management team at TCM before he transitioned to abrdn in October 2023. He holds a Bachelor of Science in Mathematics, a Medical Doctorate, and a Master of Business Administration from Tufts University. Dr. Akus combines his medical and business training in the pursuit of new opportunities to improve the portfolios and is dedicated to a team-based approach to driving investment performance.

    About abrdn

    abrdn is a global investment company that helps clients and customers plan, save, and invest for the future. abrdn's purpose is to enable its clients to be better investors. abrdn manages and administers £495bn of assets for clients (as of June 30, 2023). abrdn is structured around three businesses - Investments, Adviser and Personal - focused on their changing needs. The capabilities in abrdn's Investments business are built on the strength of its insight - generated from wide-ranging research, worldwide investment expertise and local market knowledge. abrdn's teams collaborate across regions, asset classes and specialisms, connecting diverse perspectives and working with clients to identify investment opportunities that suit their needs.

    As of June 30, 2023, abrdn's Investments business manages £367bn on behalf of clients - including insurance companies, sovereign wealth funds, independent wealth managers, pension funds, platforms, banks, and family offices. For more information on the abrdn range of closed-end funds please visit https://www.abrdn.com/en-us/cefinvestorcenter.

    Important Information

    In the United States, abrdn is the marketing name for the following affiliated, registered investment advisers: abrdn Inc., abrdn Investments Limited, abrdn Asia Limited, abrdn Private Equity (Europe) Limited, and abrdn ETFs Advisors LLC.

    Closed-end funds are traded on the secondary market through one of the stock exchanges. A Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that a Fund will achieve its investment objective. Past performance does not guarantee future results.

    The information in this press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

    https://www.abrdn.com/en-us/cefinvestorcenter

    ###

    For More Information Contact:
    abrdn U.S. Closed-End Funds
    Investor Relations
    1-800-522-5465
    [email protected]

    SOURCE: abrdn U.S. Closed-End Funds



    View the original press release on accesswire.com

    Get the next $AWP alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $AWP
    $HQH
    $HQL
    $THQ

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $AWP
    $HQH
    $HQL
    $THQ
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

      PHILADELPHIA, July 10, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, THQ, NYSE:FAX, FCO, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on July 31, 2025 to all shareholders of record as of July 24, 2025 (ex-dividend date July 24, 2025).  Ticker Exchange Fund Amount ACP NYSE abrdn Income Credit Strategies Fund $   0.0775 AGD NYSE abrdn Global Dynamic Dividend Fund $   0.1100 AOD NYSE abrdn Total Dynamic Dividend Fund $   0.1000

      7/10/25 4:17:00 PM ET
      $ACP
      $AGD
      $AOD
      $ASGI
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

      PHILADELPHIA, June 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF)  (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 30, 2025, on a per share basis to all shareholders of record as of June 23, 2025 (ex-dividend date June 23, 2025).   These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on June 30, 2025, to all shareholders of record as of May 22, 2025 (ex-dividend date May 22, 2025).

      6/30/25 4:17:00 PM ET
      $ASGI
      $HQH
      $HQL
      $IAF
      Investment Managers
      Finance
      Finance Companies
      Finance/Investors Services
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

      PHILADELPHIA, June 10, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, THQ, NYSE:AEF, FAX, FCO, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on June 30, 2025 to all shareholders of record as of June 23, 2025 (ex-dividend date June 23, 2025). Ticker Exchange Fund Amount ACP NYSE abrdn Income Credit Strategies Fund $   0.0775 AEF NYSE American Abrdn Emerging Markets ex-China Fund, Inc. $   0.1500 AGD NYSE abrdn Global Dynamic D

      6/10/25 4:17:00 PM ET
      $ACP
      $AEF
      $AGD
      $AOD
      Investment Managers
      Finance
      Finance/Investors Services
      Trusts Except Educational Religious and Charitable

    $AWP
    $HQH
    $HQL
    $THQ
    SEC Filings

    See more
    • SEC Form N-CSRS filed by abrdn Global Premier Properties Fund

      N-CSRS - abrdn Global Premier Properties Fund (0001390195) (Filer)

      7/7/25 4:27:25 PM ET
      $AWP
      Trusts Except Educational Religious and Charitable
      Finance
    • SEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial Interest

      N-CSRS - abrdn Life Sciences Investors (0000884121) (Filer)

      6/9/25 2:15:52 PM ET
      $HQL
      Investment Managers
      Finance
    • SEC Form N-CSRS filed by abrdn Healthcare Investors Shares of Beneficial Interest

      N-CSRS - abrdn Healthcare Investors (0000805267) (Filer)

      6/9/25 2:06:34 PM ET
      $HQH
      Finance Companies
      Finance

    $AWP
    $HQH
    $HQL
    $THQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Dietrick Joseph Francis

      3 - abrdn Life Sciences Investors (0000884121) (Issuer)

      7/22/25 2:40:32 PM ET
      $HQL
      Investment Managers
      Finance
    • SEC Form 3 filed by new insider Dietrick Joseph Francis

      3 - abrdn Healthcare Investors (0000805267) (Issuer)

      7/22/25 2:39:12 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form 3 filed by new insider Dietrick Joseph Francis

      3 - abrdn World Healthcare Fund (0001635977) (Issuer)

      7/22/25 2:38:32 PM ET
      $THW
      Finance Companies
      Finance

    $AWP
    $HQH
    $HQL
    $THQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Yao Nancy bought $1,990 worth of shares (500 units at $3.98), increasing direct ownership by 50% to 1,500 units (SEC Form 4)

      4 - abrdn Global Premier Properties Fund (0001390195) (Issuer)

      6/11/25 4:20:14 PM ET
      $AWP
      Trusts Except Educational Religious and Charitable
      Finance
    • Director Reit Todd bought $6,889 worth of shares (1,825 units at $3.77), increasing direct ownership by 182% to 2,825 units (SEC Form 4)

      4 - abrdn Global Premier Properties Fund (0001390195) (Issuer)

      1/10/25 11:25:49 AM ET
      $AWP
      Trusts Except Educational Religious and Charitable
      Finance
    • Director Maher Bill bought $9,990 worth of shares (650 units at $15.37) (SEC Form 4)

      4 - abrdn Life Sciences Investors (0000884121) (Issuer)

      8/27/24 2:46:40 PM ET
      $HQL
      Investment Managers
      Finance

    $AWP
    $HQH
    $HQL
    $THQ
    Leadership Updates

    Live Leadership Updates

    See more
    • abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

      PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has

      3/21/24 7:59:00 AM ET
      $AWP
      $HQH
      $HQL
      $THQ
      Trusts Except Educational Religious and Charitable
      Finance
      Finance Companies
      Investment Managers
    • Aberdeen Global Premier Properties Fund Announces Record Date And Payment Date For Monthly Distribution

      PHILADELPHIA, Jan. 12, 2021 /PRNewswire/ -- Aberdeen Global Premier Properties Fund (NYSE: AWP) (the "Fund"), a closed-end fund, today announced that it will pay on January 29, 2021, a distribution of US $0.04 per share to all shareholders of record as of January 22, 2021 (ex-dividend date January 21, 2021). The Fund's distribution policy is to provide investors with a stable monthly distribution out of current income, supplemented by realized capital gains and, to the extent necessary, paid-in capital.     Under U.S. tax rules applicable to the Fund, the amount and character of distributable income for each fiscal year can be finally determined only as of the end of the Fund's fiscal yea

      1/12/21 4:23:00 PM ET
      $AWP
      Trusts Except Educational Religious and Charitable
      Finance
    • Aberdeen Global Premier Properties Fund Announces Payment Of Monthly Distribution

      PHILADELPHIA, Jan. 8, 2021 /PRNewswire/ -- Aberdeen Global Premier Properties Fund (NYSE: AWP) (the "Fund"), a closed-end fund, today announced that it paid on January 8, 2021, a distribution of US $0.04 per share to all shareholders of record as of December 31, 2020 (ex-dividend date December 30, 2020).  Your Fund's distribution policy is to provide investors with a stable monthly distribution out of current income, supplemented by realized capital gains and, to the extent necessary, paid-in capital. Under U.S. tax rules applicable to the Fund, the amount and character of distributable income for each fiscal year can be finally determined only as of the end of the Fund's fiscal year. H

      1/8/21 4:23:00 PM ET
      $AWP
      Trusts Except Educational Religious and Charitable
      Finance

    $AWP
    $HQH
    $HQL
    $THQ
    Financials

    Live finance-specific insights

    See more
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

      PHILADELPHIA, July 10, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, THQ, NYSE:FAX, FCO, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on July 31, 2025 to all shareholders of record as of July 24, 2025 (ex-dividend date July 24, 2025).  Ticker Exchange Fund Amount ACP NYSE abrdn Income Credit Strategies Fund $   0.0775 AGD NYSE abrdn Global Dynamic Dividend Fund $   0.1100 AOD NYSE abrdn Total Dynamic Dividend Fund $   0.1000

      7/10/25 4:17:00 PM ET
      $ACP
      $AGD
      $AOD
      $ASGI
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

      PHILADELPHIA, June 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF)  (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 30, 2025, on a per share basis to all shareholders of record as of June 23, 2025 (ex-dividend date June 23, 2025).   These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on June 30, 2025, to all shareholders of record as of May 22, 2025 (ex-dividend date May 22, 2025).

      6/30/25 4:17:00 PM ET
      $ASGI
      $HQH
      $HQL
      $IAF
      Investment Managers
      Finance
      Finance Companies
      Finance/Investors Services
    • ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS

      PHILADELPHIA, June 10, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, THQ, NYSE:AEF, FAX, FCO, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on June 30, 2025 to all shareholders of record as of June 23, 2025 (ex-dividend date June 23, 2025). Ticker Exchange Fund Amount ACP NYSE abrdn Income Credit Strategies Fund $   0.0775 AEF NYSE American Abrdn Emerging Markets ex-China Fund, Inc. $   0.1500 AGD NYSE abrdn Global Dynamic D

      6/10/25 4:17:00 PM ET
      $ACP
      $AEF
      $AGD
      $AOD
      Investment Managers
      Finance
      Finance/Investors Services
      Trusts Except Educational Religious and Charitable

    $AWP
    $HQH
    $HQL
    $THQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by abrdn Healthcare Investors Shares of Beneficial Interest

      SC 13D/A - abrdn Healthcare Investors (0000805267) (Subject)

      11/18/24 4:02:58 PM ET
      $HQH
      Finance Companies
      Finance
    • Amendment: SEC Form SC 13D/A filed by abrdn Healthcare Investors Shares of Beneficial Interest

      SC 13D/A - abrdn Healthcare Investors (0000805267) (Subject)

      10/22/24 4:23:07 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

      SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

      6/3/24 9:15:41 AM ET
      $HQL
      Investment Managers
      Finance